Avengers: Endgame - Iron Man Mark 85 - Tony Stark - Mafex (No.136) - Endgame Ver.
Quick collection actions
Figure overview
Key collection stats at a glance.
Figure stats
Views
Likes
Wish
Owned
Rating
Release date
Product specs
Core release information, scale, materials, and identifiers.
- Brand
- Medicom Toy
- Sculptor
- Perfect-Studio
- Materials
- ABS, PVC
- Height / Scale
- 16 cm · 1/12
- Origin Series Name
- Avengers: Endgame
- Original Price
- ¥12,800
- Jancode
- 4530956471402
Tags
Price breakdown & trend
Follow the resale curve, compare yearly changes, and jump to live store listings.
Market snapshot
Min
-4.0%Avg
+128.5%Max
+286.0%Price comparison over time
Yearly price history
| Year | Min Price | Avg Price | Max Price |
|---|---|---|---|
| 2026 | 12,288 ¥ (+0.0%) | 29,243 ¥ (-3.4%) | 49,410 ¥ (-1.0%) |
| 2025 | 12,288 ¥ (-4.0%) | 30,278 ¥ (+136.5%) | 49,897 ¥ (+289.8%) |
| 2022 | 12,800 ¥ | 12,800 ¥ | 12,800 ¥ |
Looking to get this figure?
🔥 Good deal right now
58% below the market average of ¥28,966
2 of 9 shops have it in stock
Prices last updated on Jul 10, 2026
Your price alert
Set your target and get notified when a listing reaches it.
Alert setup
Choose your target and optionally include pre-owned offers.
Product specs
- Origin series
- Avengers: Endgame
- Brand
- Medicom Toy
- Materials
- ABS, PVC
- Sculptor
- Perfect-Studio
- Height
- 16 cm
- Scale
- 1/12
- Original price
- ¥12,800
- JAN code
- 4530956471402
Character info · Tony Stark
Quick profile references tied to this release.
- Hair color
- Black
- Hair length
- Short
- Eyes color
- Brown
- Birthday
- May 29
- Zodiac sign
- Gemini
- Height
- 185 cm
- Weight
- 83 kg
- Age
- 53 years old
- Gender
- Male
- Occupation
- Genius Billionaire Philanthropist
Character info
Tags
Gallery
Browse extra product images and collector-submitted shots for this figure.
User review articles
Long-form impressions, photos, and ownership notes from collectors.
No review article exist for this figure
Be the first one to create an article review
And get featured !
Comments
Join the discussion around this release.